Ikarian Capital, LLC 13F Holdings · Q2 2026
Ikarian Capital, LLC reported 126 securities worth $928.17M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: ABVX (13.16%), IONS (5.98%), KOD (5.36%). Among its top 25 positions this quarter: 5 new, 9 added, 10 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | $122.1M | 13.16% | 919,735 | Added |
| 2 | IONS | IONIS PHARMACEUTICALS INC | $55.5M | 5.98% | 700,000 | Added |
| 3 | KOD | KODIAK SCIENCES INC | $49.8M | 5.36% | 1.3M | Trimmed |
| 4 | XBI | SPDR SERIES TRUST | $47.5M | 5.11% | 300,000 | Trimmed |
| 5 | ALMS | ALUMIS INC | $34.5M | 3.72% | 1.2M | Trimmed |
| 6 | PRAX | PRAXIS PRECISION MEDICINES I | $31.4M | 3.38% | 93,742 | Added |
| 7 | MRNA | MODERNA INC | $28.0M | 3.02% | 400,000 | New |
| 8 | CAPR | CAPRICOR THERAPEUTICS INC | $23.0M | 2.48% | 954,215 | Added |
| 9 | ANIP | ANI PHARMACEUTICALS INC | $22.5M | 2.43% | 272,085 | Trimmed |
| 10 | PCVX | VAXCYTE INC | $22.6M | 2.43% | 388,682 | Trimmed |
| 11 | CLDX | CELLDEX THERAPEUTICS INC NEW | $22.0M | 2.38% | 592,500 | Added |
| 12 | TENX | TENAX THERAPEUTICS INC | $17.1M | 1.85% | 1.2M | Added |
| 13 | VERA | VERA THERAPEUTICS INC | $16.4M | 1.76% | 381,700 | Added |
| 14 | RCUS | ARCUS BIOSCIENCES INC | $15.6M | 1.68% | 504,559 | New |
| 15 | RLMD | RELMADA THERAPEUTICS INC | $14.9M | 1.60% | 2.1M | Trimmed |
| 16 | COGT | COGENT BIOSCIENCES INC | $14.3M | 1.54% | 370,084 | New |
| 17 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $13.6M | 1.46% | 400,000 | New |
| 18 | CTNM | CONTINEUM THERAPEUTICS INC | $13.2M | 1.43% | 807,874 | Hold |
| 19 | CCCC | C4 THERAPEUTICS INC | $11.4M | 1.22% | 2.4M | New |
| 20 | MAZE | MAZE THERAPEUTICS INC | $11.3M | 1.22% | 378,999 | Trimmed |
| 21 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $11.3M | 1.21% | 138,278 | Added |
| 22 | BHVN | BIOHAVEN LTD | $11.1M | 1.20% | 748,181 | Added |
| 23 | ANRO | ALTO NEUROSCIENCE INC | $10.7M | 1.16% | 407,338 | Trimmed |
| 24 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $10.8M | 1.16% | 4.5M | Trimmed |
| 25 | PHVS | PHARVARIS N V | $10.7M | 1.15% | 308,856 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR